Carolinas Wealth Consulting LLC Repligen Corp Transaction History

Carolinas Wealth Consulting LLC

  • $577 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023
BUY
$138.78 - $176.51 $1,387 - $1,765
10 New
10 $1,000
Q4 2020

Feb 16, 2021
SELL
$148.08 - $206.57 $2,221 - $3,098
-15 Closed
0 $0
Q3 2020

Nov 12, 2020
BUY
$122.51 - $158.27 $1,837 - $2,374
15 New
15 $2,000

Others Institutions Holding RGEN

# of Institutions
489
Shares Held
54.2M
Call Options Held
341K
Put Options Held
235K
View Full List

About REPLIGEN CORP

RGEN Quotes by TradingView
  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $8.91B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Carolinas Wealth Consulting LLC Portfolio

Follow Carolinas Wealth Consulting LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Carolinas Wealth Consulting LLC, based on Form 13F filings with the SEC.

News

Stay updated on Carolinas Wealth Consulting LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email